Rankings
▼
Calendar
AMRN Q3 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$50M
+17.4% YoY
Gross Profit
$22M
44.7% margin
Operating Income
-$11M
-22.4% margin
Net Income
-$8M
-15.6% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
-31.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$660M
Total Liabilities
$201M
Stockholders' Equity
$459M
Cash & Equivalents
$123M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50M
$42M
+17.4%
Gross Profit
$22M
$16M
+36.4%
Operating Income
-$11M
-$25M
+55.9%
Net Income
-$8M
-$25M
+69.2%
Revenue Segments
Product
$49M
98%
Licensing And Royalty
$1M
2%
Geographic Segments
UNITED STATES
$41M
91%
Europe
$4M
9%
← FY 2025
All Quarters
Q4 2025 →